Ticker
EYPTCompany Name
EYEPOINT PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt Paydown Yield | Market Capitalization | Net Cash Flow - Issuance (Repayment) of Debt Securities |
---|---|---|---|
6/30/2025 | 0.02% | $ 694.1M | $ -156K |
3/31/2025 | 0.03% | $ 419.75M | $ -140K |
12/31/2024 | 0.02% | $ 468.73M | $ -105K |
9/30/2024 | 0.01% | $ 791.03M | $ -73K |
6/30/2024 | 0% | $ 490.23M | $ 0 |
3/31/2024 | 5.56% | $ 659.91M | $ -36.66M |
12/31/2023 | 3.44% | $ 1.22B | $ -41.86M |
9/30/2023 | 15.31% | $ 273.65M | $ -41.9M |
6/30/2023 | 9.29% | $ 451.29M | $ -41.93M |
3/31/2023 | 2.28% | $ 232.57M | $ -5.3M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Debt) / Market Cap
(=) Debt Paydown Yield
Debt Paydown Yield for EYEPOINT PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Debt [ $ 2.01M ]) / Market Cap [ $ 53.43M ]
(=) Debt Paydown Yield [ -3.75% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.29K |
---|---|
min | -11.5% |
max | 11.52% |
average | -0.08% |
median | 0% |
std | 3.82% |